CAR-T Therapy (BK2113) Stock Forum and Discussion

Investment ThemesDetailed Quotes

CAR-T Therapy Watchlist

1045.407
-53.984-4.91%

Close Apr 4 16:00 ET

1086.797High1044.561Low

Constituent Stocks: 10Top Rising: BLUE+1.23%

akbarhidayat_rabka

23 hours ago

Please down to 150

$Johnson & Johnson (JNJ.US)$

Deep Sea

Apr 3 23:15

$Pfizer (PFE.US)$
Finally turn green Expect the chart to show morning star pattern.

ひな☆彡 SOXL ♡

Apr 3 21:32

kok

$Johnson & Johnson (JNJ.US)$
yesterday was the right time to sell PUT

TokenSleep

Apr 3 21:00

$Invesco QQQ Trust (QQQ.US)$ want to buy calls? Don't do it here. Not now. Let this play out. Look to pharma stocks for calls $Johnson & Johnson (JNJ.US)$

Movers and Shakers

Apr 3 20:16

Columns Today's Pre-Market Movers and Top Ratings | TSLA, AAPL, AZN and More

Morning Movers
Gapping Up
$Diageo (DEO.US)$ shares rose 4.6% in pre-market trading, as U.S. tariffs avoided the worst-case scenario for spirits. Goodbody noted no new duties on Canadian and Mexican imports, while Jefferies highlighted the avoidance of a potential 200% tariff on EU alcohol, benefiting European distillers.
Pharmaceutical shares are up in pre-market trading as drug imports could be exempt from the new 'reciprocal ta...

Trump's tariff storm sweeps the market, how to balance offense and defense?

Trytosaveabit

Apr 3 20:00

New SC 14D/9A

$bluebird bio (BLUE.US)$ Carlyle and SK Capital Partners announced the extension of their tender offer for bluebird bio from April 4 to April 18, 2025. The extension aims to allow additional time for satisfying remaining conditions, including regulatory approvals. As of April 2, approximately 65,120 shares have been validly tendered.
The offer includes $3.00 in cash per share plus one contingent value right (CVR) representing a potential additional payment of $6.84 per share, subjec...

Deep Sea

Apr 3 17:10

$Pfizer (PFE.US)$
Tonight, hope to see above 25 again since no tariffs on pharmaceutical as of now.

Teddy123

Apr 3 12:54

Novartis receives FDA accelerated approval for Vanrafia® (atrasentan), the first and only selective endothelin A receptor antagonist for proteinuria reduction in primary IgA nephropathy (IgAN)

$Novartis AG (NVS.US)$
Groundbreaking FDA Approval: Novartis Drug Shows 36% Reduction in Severe Kidney Disease Symptoms

Deep Sea

Apr 3 09:48

$Pfizer (PFE.US)$
Pharmaceutical products are among the goods that will not be subject to the reciprocal tariffs announced today, according to a White House fact sheet.
But Trump has not ruled out his plans to impose pharmaceutical-specific tariffs sometime soon.
Other goods not subject to the reciprocal tariffs include copper, semiconductors, lumber, bullion, energy and certain minerals that are not available in the U.S., the fact sheet said. It also includes products already subject to Trump’...

TRUTH808

Apr 3 04:09

$Adaptimmune Therapeutics (ADAP.US)$ IT IS "TOO" "LATE"... THEY "HAVE" TO "CORRECT" THE "NON-COMPLIANCE" BY ( APRIL 30, 2025 ), AND THEY "HAVE" "NOT" 🚫 EVEN "SCHEDULED" THE "EXTRAORDINARY GENERAL MEETING" YET, TO "APPROVE" THE "REVERSE SPLIT"... "Adaptimmune Therapeutics" ( ADAP ) "WILL" BE "DELISTED"